Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

During the Trading Day
21.21 +0.81 / +3.97%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
21.21 0.00 / 0.00%
 
Volume: 6.6K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues29.7M52.5M30.8M28.1M
 
 
 
 
 
Cost of Goods Sold1.4M1.1M2.1M1.4M
 
 
 
 
 
Depreciation And Amortization233.0K241.0K227.0K214.0K
 
 
 
 
 
 
Operating ExpensesGross Income28.0M51.2M28.5M26.5M
 
 
 
 
 
General Expenses24.3M22.0M23.8M23.1M
 
 
 
 
 
Research And Development4.7M4.7M5.8M3.7M
 
 
 
 
 
Total Operating Expenses25.9M23.3M26.1M24.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.8M29.2M4.7M3.4M
 
 
 
 
 
Extraordinary Credit678.0K760.0K694.0K0.00
 
 
 
 
Extraordinary Charge-39.0K-860.0K0.00-2.2M
 
 
 
 
Interest Expense On Debt1.3M1.3M1.2M381.0K
 
 
 
 
 
Other Expenses0.002.0K37.0K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.2M27.9M4.4M979.0K
 
 
 
 
 
Income Taxes0.000.000.00-62.0K
 
 
Net Income3.2M27.9M4.4M917.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.1M42.9M42.9M44.6M
 
 
 
 
 
Shares To Calculate EPS Diluted42.4M50.8M43.2M44.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.08$0.39$0.10$0.02
 
 
 
 
 
EPS Diluted$0.08$0.39$0.10$0.02